Avinger Company Profile (NASDAQ:AVGR)

Analyst Ratings

Consensus Ratings for Avinger (NASDAQ:AVGR) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $19.33 (213.85% upside)

Analysts' Ratings History for Avinger (NASDAQ:AVGR)
Show:
DateFirmActionRatingPrice TargetActions
7/15/2016BTIG ResearchReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Dougherty & CoDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015StephensInitiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Avinger (NASDAQ:AVGR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
5/4/2016Q1($1.17)($1.28)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2016Q4($1.04)($1.07)$2.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.88)($1.08)$3.10 million$2.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215($0.90)($0.83)$2.72 million$3.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q1($1.15)($1.53)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.77)($33.62)$3.10 million$3.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Avinger (NASDAQ:AVGR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($1.17)($1.17)($1.17)
Q2 20161($1.18)($1.18)($1.18)
Q3 20161($1.10)($1.10)($1.10)
Q4 20161($1.02)($1.02)($1.02)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Avinger (NASDAQ:AVGR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Avinger (NASDAQ:AVGR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/20/2016John D SimpsonVPSell32,500$6.28$204,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Donald A LucasDirectorSell9,309$12.58$117,107.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Himanshu PatelInsiderSell10,000$13.40$134,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016John B Ph D Md SimpsonMajor ShareholderSell75,111$13.11$984,705.21View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016John B Ph D Md SimpsonMajor ShareholderSell40,000$11.44$457,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Matthew FergusonCFOBuy1,500$11.37$17,055.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/14/2015Donald A LucasDirectorSell2,500$16.22$40,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Donald A LucasDirectorSell4,000$15.92$63,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015John B Ph D Md SimpsonMajor ShareholderSell100,000$17.26$1,726,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015John B Ph D Md SimpsonChairmanSell42,445$17.20$730,054.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Himanshu PatelCTOSell1,731$13.00$22,503.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015James CullenDirectorSell2,307$13.00$29,991.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Matthew FergusonCFOSell1,154$13.00$15,002.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Avinger (NASDAQ:AVGR)
DateHeadline
07/22/16 02:39 PMEarnings Focus and Crowd Sourced Sentiment Review for Avinger, Inc. (NASDAQ:AVGR) - TGP
07/22/16 02:39 PMShares Nearing a Recent Low: Avinger, Inc. (NASDAQ:AVGR) - Press Telegraph
07/21/16 02:39 PMAvinger, Inc. (AVGR) Current Analyst Ratings - Fiscal Standard
07/20/16 10:45 AMAvinger, Inc. (NASDAQ:AVGR) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/19/16 08:03 PMInvestigation for Investors in Shares of Avinger Inc (NASDAQ:AVGR) Announced
07/19/16 02:41 PMInvestigation for Investors in Shares of Avinger Inc (NASDAQ:AVGR) Announced - Digital Journal
07/18/16 12:28 PMETF’s with exposure to Avinger, Inc. : July 18, 2016 -
07/17/16 07:23 AMShares Moving Down on the Week: Avinger, Inc. (NASDAQ:AVGR) - Engelwood Daily
07/16/16 02:37 PMNoting Unusual Volume on Shares of Avinger, Inc. (NASDAQ:AVGR) - Engelwood Daily
07/16/16 02:37 PMBulls and Bear in Spotlight- Avinger (NASDAQ:AVGR), CSX (NASDAQ:CSX), John Hancock Financial Opportunities ... - Seneca Globe
07/16/16 02:37 PMShares Experiencing a Downtrend: Avinger, Inc. (NASDAQ:AVGR) - TGP
07/14/16 02:43 PMINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal …
07/14/16 01:00 PMINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Avinger, Inc. - AVGR - [PR Newswire] - NEW YORK, July 14, 2016 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Avinger, Inc. (NASDAQ: AVGR) ("Avinger") concerning possible violations of federal securities ...
07/14/16 12:01 PMHere’s Why Markets and Avinger Inc (AVGR) Just Gave Us An Oversold Opportunity -
07/14/16 11:34 AMHere’s Why Markets and Avinger Inc (NASDAQ:AVGR) Just Gave Us An Oversold Opportunity
07/14/16 11:34 AMAvinger Inc. (AVGR) Sank To A New Low After Forecast Disappoints
07/13/16 04:51 PMIMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Avinger, Inc. and Reminds Investors with Losses to Contact the Firm - [Business Wire] - Khang & Khang LLP announces that it is investigating claims against Avinger, Inc. concerning possible violations of federal securities laws.
07/13/16 02:41 PMAvinger (AVGR) Prelim. Q2 Revenue Misses Views
07/13/16 02:41 PMAvinger Shareholder Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation …
07/13/16 02:41 PMAnalyst Update: Tripadvisor Inc, FreightCar America, Inc., and Avinger Inc
07/13/16 02:41 PMAvinger (AVGR) Misses Mark with Preliminary Q2 Financial Results
07/13/16 02:22 PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by Certain Officers and Directors of Avinger, Inc. - [Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Avinger, Inc. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
07/13/16 11:45 AMAvinger Inc. (AVGR) Lowers Guidance, Stock Down 40% -
07/13/16 10:29 AMAvinger Shareholder Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Avinger, Inc.; Investors Encouraged to Contact Firm - [PR Newswire] - SAN DIEGO, July 13, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Avinger, Inc. (NASDAQ: AVGR). Avinger ...
07/12/16 03:33 PMAvinger, Inc. Announces Preliminary Second Quarter 2016 Revenue Results - [at noodls] - REDWOOD CITY, Calif., July 12, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that based on preliminary ...
07/12/16 03:05 PMAVINGER INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
07/08/16 12:50 PMEdited Transcript of AVGR earnings conference call or presentation 4-May-16 8:30pm GMT -
06/27/16 03:21 PMHighmark Health’s VITAL Program to Evaluate Avinger’s Novel Treatment for Peripheral Artery Disease - [at noodls] - PITTSBURGH and REDWOOD CITY, Calif., June 27, 2016 (GLOBE NEWSWIRE) -- Highmark Health, Allegheny Health Network (AHN) and Avinger, Inc. (NASDAQ:AVGR) announced a collaboration today to evaluate Pantheris™, ...
06/27/16 07:23 AMAvinger (AVGR) Looks Good: Stock Adds 5.4% in Session
06/26/16 06:59 AMThese 5 Stocks Are Ready to Break Out Now -
06/17/16 03:02 PMAVINGER INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet -
06/15/16 03:19 PMAvinger, Inc. Announces Drawdown of $10 Million Under Term Loan Facility with CRG - [at noodls] - REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it has completed ...
06/15/16 03:05 PM4:05 pm Avinger completes second drawdown from term loan facility w/ CRG for proceeds of $10 million before closing fees -
06/07/16 03:03 PMAVINGER INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/26/16 06:14 PMETF’s with exposure to Avinger, Inc. : May 26, 2016 -
05/26/16 01:51 PMEarnings Review and Stock Rundown for Avinger, Inc. (NASDAQ:AVGR) - Wall Street Hints and News - Earnings Review and Stock Rundown for Avinger, Inc. (NASDAQ:AVGR)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Avinger, Inc. (NASDAQ:AVGR) to post ...and more »
05/16/16 09:45 AMAvinger, Inc. :AVGR-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/09/16 04:00 PMAVINGER INC Files SEC form 10-Q, Quarterly Report -
05/04/16 04:21 PMAvinger reports 1Q loss -
05/04/16 03:31 PMAvinger, Inc. Announces First Quarter 2016 Results - [at noodls] - REDWOOD CITY, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first ...
05/04/16 03:30 PMAvinger Inc Earnings Call scheduled for 4:30 pm ET today -
05/04/16 03:09 PMAVINGER INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and -
05/04/16 06:07 AMQ1 2016 Avinger Inc Earnings Release - After Market Close -
04/27/16 03:27 PMAvinger, Inc. to Announce First Quarter 2016 Results on Wednesday, May 4, 2016 - [at noodls] - REDWOOD CITY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release ...
04/11/16 11:24 AMEdited Transcript of AVGR earnings conference call or presentation 1-Mar-16 9:30pm GMT -
03/24/16 09:50 AMThese 5 Under-$10 Stocks Are Set to Soar Higher -
03/16/16 09:27 AMAvinger (AVGR): Moving Average Crossover Alert -
12/23/15 03:07 PMAVINGER INC Files SEC form 8-K, Change in Directors or Principal Officers -
12/23/15 08:27 AMAvinger, Inc. Earnings Analysis: Q3, 2015 By the Numbers -
12/08/15 12:17 PMAVINGER INC Financials -

Social

About Avinger

Avinger logoAvinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and select European markets. The Company's products include Lightbox imaging console, as well as Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The Company's lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVGR
  • CUSIP:
Key Metrics:
  • Previous Close: $6.27
  • 50 Day Moving Average: $10.24
  • 200 Day Moving Average: $12.38
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $78.19M
  • Beta: 0.1
  • Current Year EPS Consensus Estimate: $-4.49 EPS
  • Next Year EPS Consensus Estimate: $-3.39 EPS
Additional Links:
Avinger (NASDAQ:AVGR) Chart for Sunday, July, 24, 2016